Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Journal of Cellular and Molecular Medicine|June 28, 2022
Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advancesMarzieh Nikoo, Mohammad Rudiansyah, Dmitry Olegovich Bokov, et al.Human Immunology|July 7, 2021
Humoral immune mechanisms involved in protective and pathological immunity during COVID-19Gunawan Widjaja, Abduladheem Turki Jalil, Heshu Sulaiman Rahman, et al.Analytical Biochemistry|June 1, 2022
Optical-based biosensor for detection of oncomarker CA 125, recent progress and current statusAlexei Valerievich Yumashev, Mohammad Rudiansyah, Supat Chupradit, et al.Cell Communication and Signaling : CCS|April 8, 2022
Cancer combination therapies by angiogenesis inhibitors; a comprehensive reviewMohammad Javed Ansari, Dmitry Bokov, Alexander Markov, et al.European Journal of Pharmacology|August 15, 2021
Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatmentArezoo Gowhari Shabgah, Wanich Suksatan, Muhammad Harun Achmad, et al.Frontiers in Psychology|June 27, 2022
Intolerance of Uncertainty Scale-12: Psychometric Properties of This Construct Among Iranian Undergraduate StudentsBalachandran Vadivel, Zahra Azadfar, Mansor Abu Talib, et al.Journal of Translational Medicine|July 13, 2021
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicineSoudeh Moghadasi, Marischa Elveny, Heshu Sulaiman Rahman, et al.International Immunopharmacology|February 1, 2022
Mesenchymal stromal/stem cells and their exosomes application in the treatment of intervertebral disc disease: A promising frontierGunawan Widjaja, Abduladheem Turki Jalil, Hendrik Setia Budi, et al.Cell Communication and Signaling : CCS|April 8, 2022
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and consAdel Naimi, Rebar N Mohammed, Ahmed Raji, et al.Clinical and Experimental Immunology|January 12, 2022
Does CCL19 act as a double-edged sword in cancer development?Arezoo Gowhari Shabgah, Zaid Mahdi Jaber Al-Obaidi, Heshu Sulaiman Rahman, et al.Pageof 8